It has been …
… since Prime Minister Boris Johnson said "We owe it to future generations to build back better and base our recovery on solid foundations, including a fairer, greener and more resilient global economy."
We need at least US $52 billion to fund the global response to the COVID-19 pandemic in 2022. Grant financing by donor countries accounts for at least US $27.7 billion, or 53%, of this. Governments must act fast to fill this funding gap. To date, US $2.3 billion has been committed by members of the G20.
US $1.3 billion fair share ask
US $78.0 million contributedas of 10 March 2022
6% of fair share contributed
Only a handful of countries have the capacity to manufacture vaccines. We need urgent action to share mRNA technology and intellectual property rights, and to adapt existing facilities and acquire the materials needed to scale up vaccine production globally.
Does not endorse the TRIPS waiver
as of 16 December 2021
Is supporting efforts to increase regional manufacturing capacity
14 December 2021
The pandemic’s aftershocks continue to devastate the economies of many countries. High-income countries must support more vulnerable nations with all tools available, including Special Drawing Rights (SDRs), an international reserve asset that can help support countries in emergencies. Rechannelling an initial $100 billion of SDRs in 2021 to low income and vulnerable middle income countries is a smart investment in a fairer, greener, and better recovery for everyone. To date, $60 billion has been committed from all advanced economies.
US $27 billion receivedon 23 August 2021
US $5.5 billion pledged
as of 14 October 2021
86% of fair share of $100bn SDR recycling in 2021
US $2.0 billion pledged
on on 15 December 2021
-54% below IDA19 pledge
Does not support ambitious IDA replenishment/$100bn ask
Low and lower-middle income countries still need nearly 1.9 billion doses to fully vaccinate 70% of the population by mid-2022. To help close the gap, members of the G20 have promised to share over 2.7 billion doses by mid-2022. To date, 1.31 billion have been delivered. Note: in response to calls from Africa CDC to pause vaccine donations until the second half of 2022, scoring for the delivery of doses was last updated on 17 February 2022 to reflect how well donors delivered on commitments when there were significant constraints on the supply of COVID-19 vaccines. Deliveries and updates to published dose delivery will continue to be monitored.
The United Kingdom has not published a dose delivery plan.
100 million pledgedon 15 June 2021
41.5 million deliveredas of 11 August 2022
The UK has publicly supported the need for a coherent global response to the pandemic, including the economic crisis. It has pledged to recycle Special Drawing Rights (SDRs) to support vulnerable countries. However, the UK’s decision to cut its aid budget from 0.7% to 0.5% of GNI means that every new commitment for vaccines, the recycling of SDRs, and other initiatives comes at the cost of existing programming.
The UK has committed to share a total of 100 million doses, including 30 million by the end of 2021, placing the UK sixth among G7 countries. To date, the UK has delivered 41.5 million doses*. ONE is calling on the UK to share at least 100 million doses by spring 2022. The UK must raise its ambition for both the total volume and pace of dose-sharing, and also publish up to date data on dose sharing, including use-by-dates and vaccine type. In addition, the UK should stop over-purchasing doses to ensure available supply for Covax and countries that have yet to administer first and second doses.
The UK committed $1.1 billion of the $1.6 billion it was asked to pledge to the Access to COVID-19 Tools Accelerator (ACT-A) in 2020 and 2021. The UK should commit £1 billion in 2022 to fulfill its fair share of the financing needed to ensure that 70% of the population, across every income grouping, can be vaccinated by September 2022.
The UK has also committed to recycling 20% of its Special Drawing Rights (SDRs), including an initial £1 billion commitment to the IMF’s Poverty Reduction and Growth Trust. However, this funding will be counted under the UK’s aid budget, meaning that low- and middle-income countries will not see any net benefit, as other aid will be reduced accordingly. This contradicts earlier claims that the new SDR issuance would result in additional financing for the poorest countries. In 2022, the UK must commit to more ambitious SDR recycling targets and ensure this funding is additional to the 0.5% aid budget.
*On 30th December the UK announced that it had shared a total of 30.1 million doses. Note that ONE is using Airfinity data for consistency across countries, and that this data accounts for the number of doses that have been delivered to countries - which for UK dose donations stands at 41.5 million doses.